|
20 Apr 2007 |
Access Pharmaceuticals Signs Definitive Merger Agreement With Somanta Pharmaceuticals
|
|
19 Apr 2007 |
Completion of Phase I Trial on the Anti-influenza Drug CS-8958
|
|
19 Apr 2007 |
Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
|
|
19 Apr 2007 |
Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
|
|
19 Apr 2007 |
Viragen Announces European Multiferon(R) Licensing Agreement
|
|
18 Apr 2007 |
DeveloGen and Andromeda, a newly formed wholly-owned subsidiary of Clal Biotechnology Industries, Sign Term Sheet for Asset Purchase Agreement for the DiaPep277(R) Program
|
|
18 Apr 2007 |
Wockhardt to soon introduce Kelocote to treat scars
|
|
18 Apr 2007 |
Wockhardt to soon introduce Kelocote to treat scars
|
|
18 Apr 2007 |
Prevascar Phase II Results
|
|
18 Apr 2007 |
Salix Pharmaceuticals Licenses DIACOL(TM) To Dr. Falk Pharma in Europe
|
|
17 Apr 2007 |
Cambridge Antibody Technology and Philochem Announce Technology Evaluation Agreement
|
|
17 Apr 2007 |
Arrowhead Subsidiaries Insert & Calando Present Data on Cyclosert Drug Delivery System at AACR Meeting
|
|
17 Apr 2007 |
Regulatory Review Allows LCT Diabetes Clinical Program to Proceed
|
|
17 Apr 2007 |
Metabasis Therapeutics Presents Results of a Clinical Study for Its Novel Liver-Targeted Product Candidate for the Treatment of HCC at American Association for Cancer Research
|
|
14 Apr 2007 |
Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275
|
|
14 Apr 2007 |
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
|
|
13 Apr 2007 |
MedImmune Explores Strategic Alternatives
|
|
13 Apr 2007 |
Intarcia Therapeutics Announces Final Results From A Phase 2 Study Of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
|
|
13 Apr 2007 |
Coley Pharmaceutical Group Licenses VaxImmune(TM) to Merck for Use in Vaccine Programs
|
|
13 Apr 2007 |
Ranbaxy Receives FDA Approval To Market Loratadine Antihistamine Tablets
|
|
13 Apr 2007 |
Anika Therapeutics Receives CE Mark Approval for its Cosmetic Tissue Augmentation Product ELEVESS(TM) to be Marketed by Galderma
|
|
12 Apr 2007 |
Roche and Transgene enter partnership on therapeutic vaccines against HPV-mediated diseases
|
|
12 Apr 2007 |
Novosom AG Acquires Exclusive Option for CD40-Targeted Antisense Inhibitors From Isis Pharmaceuticals
|
|
12 Apr 2007 |
Xanthus Acquires from Johns Hopkins University Exclusive License to Patent Estate Covering FLT3 Pathway as a Target for Treating Autoimmune Diseases
|
|
12 Apr 2007 |
Repligen Licenses Potential Treatment for Friedreich's Ataxia from The Scripps Research Institute
|
